These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins: no effect on ablation outcome after ablation of atrial fibrillation. Richter B; Derntl M; Marx M; Lercher P; Gössinger HD Am Heart J; 2007 Jan; 153(1):113-9. PubMed ID: 17174648 [TBL] [Abstract][Full Text] [Related]
4. Adjuvant therapy for atrial fibrillation. Mohammed KS; Kowey PR; Musco S Future Cardiol; 2010 Jan; 6(1):67-81. PubMed ID: 20014988 [TBL] [Abstract][Full Text] [Related]
5. The role of renin angiotensin system blockade in the treatment of atrial fibrillation. Dilaveris P; Giannopoulos G; Synetos A; Stefanadis C Curr Drug Targets Cardiovasc Haematol Disord; 2005 Oct; 5(5):387-403. PubMed ID: 16248831 [TBL] [Abstract][Full Text] [Related]
6. Atrial fibrillation: Blockade of the renin-angiotensin system in atrial fibrillation. Kuzniatsova N; Shantsila E; Lip GY Nat Rev Cardiol; 2010 Aug; 7(8):428-30. PubMed ID: 20657612 [No Abstract] [Full Text] [Related]
7. Role of renin-angiotensin system inhibitors in atrial fibrillation. Disertori M; Latini R; Maggioni AP J Cardiovasc Med (Hagerstown); 2011 May; 12(5):374; author reply 375. PubMed ID: 21451337 [No Abstract] [Full Text] [Related]
8. Focus on renin-angiotensin system modulation and atrial fibrillation control after GISSI AF results. Durin O; Pedrinazzi C; Inama G J Cardiovasc Med (Hagerstown); 2010 Dec; 11(12):912-8. PubMed ID: 20729747 [TBL] [Abstract][Full Text] [Related]
9. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials. Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638 [TBL] [Abstract][Full Text] [Related]
10. Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention. Savelieva I; Kakouros N; Kourliouros A; Camm AJ Europace; 2011 Mar; 13(3):308-28. PubMed ID: 21345926 [TBL] [Abstract][Full Text] [Related]
11. [Upstream therapy of atrial fibrillation in patients with heart failure]. Alboni P; Gianfranchi L; Pacchioni F G Ital Cardiol (Rome); 2009 Sep; 10(9):566-71. PubMed ID: 19891248 [TBL] [Abstract][Full Text] [Related]
12. Drug therapy for atrial fibrillation. Conway EL; Musco S; Kowey PR Cardiol Clin; 2009 Feb; 27(1):109-23, ix. PubMed ID: 19111768 [TBL] [Abstract][Full Text] [Related]
13. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers decrease the incidence of atrial fibrillation: a meta-analysis. Huang G; Xu JB; Liu JX; He Y; Nie XL; Li Q; Hu YM; Zhao SQ; Wang M; Zhang WY; Liu XR; Wu T; Arkin A; Zhang TJ Eur J Clin Invest; 2011 Jul; 41(7):719-33. PubMed ID: 21250983 [TBL] [Abstract][Full Text] [Related]